For the quarter ending 2026-03-31, TELA has $69,891K in assets. $75,092K in debts. $39,541K in cash and cash equivalents.
| Balance Sheets | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 |
|---|---|---|---|---|
| Cash and cash equivalents | 39,541 | 50,845 | 29,713 | 34,977 |
| Accounts receivable, net of allowances of 424 and 287 | 9,715 | 10,347 | 11,274 | 11,236 |
| Inventory | 12,213 | 11,016 | 11,558 | 11,371 |
| Prepaid expenses and other current assets | 2,833 | 3,373 | 3,503 | 3,161 |
| Total current assets | 64,302 | 75,581 | 56,048 | 60,745 |
| Property and equipment, net | 2,157 | 2,226 | 2,213 | 2,167 |
| Intangible assets, net | 1,264 | 1,359 | 1,454 | 1,549 |
| Right-of-use assets | 1,442 | 1,502 | 1,560 | 1,616 |
| Deferred tax asset, net | - | - | 62 | 64 |
| Other long-term assets | 476 | 500 | - | 1,131 |
| Restricted cash | 250 | 250 | 250 | 265 |
| Total assets | 69,891 | 81,418 | 61,587 | 67,537 |
| Current portion of long-term debt | - | - | - | 3,333 |
| Accounts payable | 3,894 | 2,309 | 2,373 | 1,741 |
| Accrued expenses and other current liabilities | 13,939 | 15,666 | 14,604 | 13,987 |
| Total current liabilities | 17,833 | 17,975 | 16,977 | 19,061 |
| Long-term debt | 55,866 | 55,653 | 41,494 | 38,051 |
| Other long-term liabilities | 1,393 | 1,477 | 1,559 | 1,241 |
| Total liabilities | 75,092 | 75,105 | 60,030 | 58,353 |
| Common stock 0.001 par value 200,000,000 shares authorized 44,765,928 and 44,538,264 shares issued and outstanding at march 31, 2026 and december 31, 2025, respectively | 45 | 44 | 40 | 40 |
| Additional paid-in capital | 404,503 | 403,739 | 389,946 | 388,968 |
| Accumulated other comprehensive income | 85 | 91 | 91 | 93 |
| Accumulated deficit | -409,834 | -397,561 | -388,520 | -379,917 |
| Total stockholders' (deficit) equity | -5,201 | 6,313 | 1,557 | 9,184 |
| Total liabilities and stockholders' (deficit) equity | 69,891 | 81,418 | 61,587 | 67,537 |
TELA Bio, Inc. (TELA)
TELA Bio, Inc. (TELA)